Skeletal Muscle Loss During Neoadjuvant Chemotherapy for Breast Cancer: Diabetes as an Independent Predictor

NACT is associated with significant reductions in skeletal muscle and subcutaneous fat, together with increased rates of LSMM. Diabetes mellitus independently predicted lower post-treatment SMI.